BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1717210)

  • 21. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis.
    Iddings D; Ahmad A; Elashoff D; Bilchik A
    Ann Surg Oncol; 2006 Nov; 13(11):1386-92. PubMed ID: 17009147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H; Saito Y; Kirihara Y; Takashima J
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
    Fernandes LC; Kim SB; Saad SS; Matos D
    World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis between multilevel sectioning with conventional haematoxylin and eosin staining and immunohistochemistry for detecting nodal micrometastases with stage I and II colorectal cancers.
    Wong YP; Shah SA; Shaari N; Mohamad Esa MS; Sagap I; Isa NM
    Asian Pac J Cancer Prev; 2014; 15(4):1725-30. PubMed ID: 24641399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.
    Choi HJ; Choi YY; Hong SH
    Dis Colon Rectum; 2002 Jun; 45(6):750-5; discussion755-6. PubMed ID: 12072625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of a mixture of three types of antibodies for immuno-histologic detection of stomach cancer micrometastases].
    Pugachev KK; Shimbireva IB
    Arkh Patol; 1991; 53(1):66-8. PubMed ID: 1859287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoperoxidase staining of carcinoembryonic antigen as a prognostic indicator in colorectal carcinoma.
    Cunningham L; Stocking B; Halter SA; Kalemeris G
    Dis Colon Rectum; 1986 Feb; 29(2):111-6. PubMed ID: 3510834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokeratin immunostaining reveals micrometastasis in negative hematoxylin-eosin lymph nodes of resected stage I-II (pT2-pT3) colorectal cancer.
    Bertoglio S; Percivale P; Gambini C; Dicasa D; Meszaros P; Sciallero S; Bruzzi P; Badellino F
    J Chemother; 1997 Apr; 9(2):119-20. PubMed ID: 9176752
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
    Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
    Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral and mesenteric serum levels of CEA and cytokeratins, staging and histopathological variables in colorectal adenocarcinoma.
    Ivankovics IG; Fernandes LC; Saad SS; Matos D
    World J Gastroenterol; 2008 Nov; 14(43):6699-703. PubMed ID: 19034974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.
    Mori M; Mimori K; Inoue H; Barnard GF; Tsuji K; Nanbara S; Ueo H; Akiyoshi T
    Cancer Res; 1995 Aug; 55(15):3417-20. PubMed ID: 7542169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma.
    Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 1994; 51(3):228-33. PubMed ID: 7515172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo sentinel lymph node mapping in colorectal cancer.
    Bell SW; Mourra N; Fléjou JF; Parc R; Tiret E
    Dis Colon Rectum; 2005 Jan; 48(1):74-9. PubMed ID: 15690661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen in carcinoma of the uterine cervix: antigen distribution in primary and metastatic tumors.
    van Nagell JR; Hudson S; Gay EC; Donaldson ES; Hanson M; Powell DF; Goldenberg DM
    Cancer; 1982 Jan; 49(2):379-83. PubMed ID: 6274508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma.
    Lee E; Chae Y; Kim I; Choi J; Yeom B; Leong AS
    Cancer; 2002 Jun; 94(11):2867-73. PubMed ID: 12115374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of micrometastases in pN0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry.
    Franco MR; Parra ER; Takagaki TY; Soares FA; Capelozzi VL
    J Bras Pneumol; 2008 Mar; 34(3):129-35. PubMed ID: 18392460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.